Health
New antitumor vaccines control melanoma growth in preclinical models – News-Medical.Net
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical m…
Reviewed by Emily Henderson, B.Sc.Sep 11 2020
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
Study results were published online in Cancer Immunology Research, a journal of the American Association for Cancer Research, and support exploration of this immunotherapy approach for a…
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
Noosa News19 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News23 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct